Quarterly report · Q2
4320.TEDINET S100QQ1L
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥13.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥840m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥616m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥838m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥861m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥495m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥588m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥336m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥536m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥378m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥11.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥11.4bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥289m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥254m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥764m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥891m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥194m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥307m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥535m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥32.99 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.13 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.38 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.85 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥26m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥873m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥8m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥865m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥60m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥681m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥5m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥676m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -99963000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -633000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -894000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | 45220000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | 39050000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -119511000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -180407000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -44100000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -39200000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | 534778000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -193970000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 1119877000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -736958000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 2865030000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 3958521000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 3984907000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 3221562000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 346206000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 402816000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 10674000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 8552000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 7061000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 5037000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 90076000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 98217000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 92000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 4198000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 7214036000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 19186000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 7233223000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 7233223000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E05233-000MarketingSolutionBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 7214036000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 19186000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 7233223000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 7233223000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 680881000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E05233-000MarketingSolutionBusinessReportableSegmentsMember | -5137000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 675743000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -59593000 | JPY |
| Operating income | Prior1YTDDuration | 616150000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 7101473000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 239868000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |